Filing Details

Accession Number:
0001179110-10-002721
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-02-12 12:00:00
Reporting Period:
2010-02-10
Filing Date:
2010-02-12
Accepted Time:
2010-02-12 17:08:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1410289 T Mary Szela 100 Abbott Park Road
Abbott Park IL 60064-6400
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2010-02-10 57 $50.70 125,914 No 4 M Direct
Common Shares Without Par Value Acquisiton 2010-02-10 390 $53.00 126,304 No 4 M Direct
Common Shares Without Par Value Disposition 2010-02-10 347 $53.21 125,957 No 4 S Direct
Common Shares Without Par Value Disposition 2010-02-10 100 $53.23 125,857 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Option (right to buy) Disposition 2010-02-10 57 $0.00 57 $50.70
Common Shares Option (right to buy) Disposition 2010-02-10 390 $0.00 390 $53.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2002-11-02 2010-02-10 No 4 M Direct
0 2008-11-07 2010-02-10 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares Without Par Value 74 Indirect Profit Sharing Trust
Footnotes
  1. Balance in the Abbott Laboratories Stock Retirement Trust as of February 10, 2010.
  2. Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.